Next-Generation Dialysis System with Real-Time Blood Solute Monitoring and Personalized Treatment

A futuristic dialysis system integrating wearable/implantable devices, AI-powered sensors, and modular sorbent cartridges for real-time blood solute monitoring, personalized treatment, and autonomous adaptation to patient needs.

The original patent's recirculating dialysate fluid circuit, while innovative, has limitations in terms of real-time monitoring, patient personalization, and autonomous adaptation. The new inventive concept addresses these limitations by envisioning a next-generation dialysis system that leverages advanced technologies to provide more effective and efficient treatment.

The new inventive concept comprises a wearable/implantable device integrating a sorbent cartridge and micro-sensor array for continuous measurement of blood solute levels during dialysis therapy. The system features a wireless communication module for transmitting data to a remote server or healthcare provider. Additionally, the system includes a modular, AI-powered central processing unit, a sensor array, and interchangeable sorbent cartridges optimized for specific blood solutes or patient populations. The system is capable of real-time adaptation to changing patient conditions and treatment goals, ensuring personalized treatment. The closed-loop, autonomous system integrates real-time sensor data, patient history, and treatment goals to optimize dialysate composition, flow rate, and sorbent cartridge properties, automatically adjusting system parameters to maintain optimal treatment conditions.

The new claims introduce a paradigm shift in dialysis technology by integrating wearable/implantable devices, AI-powered sensors, and modular sorbent cartridges, enabling real-time monitoring, personalized treatment, and autonomous adaptation. These features are non-obvious and novel compared to the original patent, which focused on recirculating dialysate fluid circuits.

Alternative embodiments may include variations in sensor array design, sorbent cartridge materials, and AI algorithm implementation. Additionally, the system could be adapted for use in other medical applications, such as monitoring blood glucose levels or detecting biomarkers for diseases.

The next-generation dialysis system has significant commercial potential in the medical device industry, particularly in the areas of chronic kidney disease treatment, personalized medicine, and remote patient monitoring. The system's ability to provide real-time monitoring, personalized treatment, and autonomous adaptation makes it an attractive solution for healthcare providers, patients, and payers.